Lixisenatide

Description

Short Overview

Lixisenatide is a selective GLP-1 receptor agonist peptide based on exendin-4 structure. It is studied in metabolic disease research for its postprandial glucose control and gastric emptying modulation properties. Manufactured with high purity standards, Lixisenatide peptide is supplied in lyophilized powder form for convenient handling and long-term stability in research settings.

Product Specifications

Product Name: Lixisenatide

Category: Peptide

CAS Number: 9001-62-1

Form: Lyophilized Powder

Purity: High-grade research quality

Storage: Store refrigerated (2-8 degrees C) for optimal stability

Available Variants

Key Features

• High-purity Lixisenatide peptide
• Lyophilized for improved stability and storage
• Consistent batch quality for research reliability
• Available in 5 mg and 10 mg vial packaging
• Secure packaging for laboratory use

Research Applications

• Lixisenatide is commonly used in studies involving:
• Postprandial glucose regulation studies
• GLP-1 receptor pharmacology research
• Gastric emptying rate modulation analysis
• Type 2 diabetes combination therapy studies
• Incretin-based therapy mechanism research

Handling and Storage

• Store in a cool and dry place.
• For long-term storage, keep at 2-8 degrees C or frozen.
• Avoid repeated freeze-thaw cycles.

Important Disclaimer

This product is intended for laboratory research purposes only. It is not intended for human consumption, medical, veterinary, or household use.